The ROE as of June 2026 (TTM) for Dermata Therapeutics, Inc. (DRMA) is -127.91%

According to Dermata Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -127.91%. This represents a change of 288.34% compared to the average of -32.94% of the last 4 quarters.

Dermata Therapeutics, Inc. (DRMA) Historical ROE (quarterly & annually)

How has DRMA ROE performed in the past?

The mean historical ROE of Dermata Therapeutics, Inc. over the last ten years is 154.20%. The current -127.91% ROE has changed -182.95% with respect to the historical average. Over the past ten years (40 quarters), DRMA's ROE was at its highest in in the June 2021 quarter at 263.30%. The ROE was at its lowest in in the March 2021 quarter at -323.73%.

Dermata Therapeutics, Inc. (DRMA) ROE by Quarter and Year

Discovering the peaks and valleys of Dermata Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Dermata Therapeutics, Inc. (DRMA) Average ROE

How has DRMA ROE performed in the past?

The current ROE of Dermata Therapeutics, Inc. (DRMA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Dermata Therapeutics, Inc. (DRMA) ROE vs. Peers

How is DRMA’s ROE compared to its peers?

Dermata Therapeutics, Inc.’s ROE is greater than Avenue Therapeutics, Inc. (-65.83%), greater than Windtree Therapeutics, Inc. (-1302.82%), greater than Carisma Therapeutics, Inc. (-28.86%), greater than Psyence Biomedical Ltd. (-47.61%), greater than Lipella Pharmaceuticals Inc. (-208.44%), greater than Virax Biolabs Group Limited (-102.54%), greater than PMGC Holdings Inc. (-116.96%), greater than GT Biopharma, Inc. (-901.32%), greater than Revelation Biosciences, Inc. (-107.66%), greater than Artelo Biosciences, Inc. (-1602.50%),

Build a custom stock screener for Dermata Therapeutics, Inc. (DRMA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dermata Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Dermata Therapeutics, Inc. (DRMA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Dermata Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.